MPC2 and neoplasm: The role of glycolytic pathways in tumor progression can be weakened by inhibiting the pyruvate to lactic acid conversion but transferring this metabolite to mitochondria through mitochondrial pyruvate complex (MPC) composed of two complexes: MPC1 and MPC2 [16–18].